Treatment of couples with unexplained subfertility and an unfavourable prognosis: a randomised trial comparing the effectiveness of intrauterine insemination with ovarian hyperstimulation and in-vitro fertilisation with single embryo transfer
ISRCTN | ISRCTN86744378 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN86744378 |
Secondary identifying numbers | NL811, NTR824 |
- Submission date
- 28/12/2006
- Registration date
- 28/12/2006
- Last edited
- 14/01/2021
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr I Custers
Scientific
Scientific
Academic Medical Center (AMC)
Department of Obstetrics and Gynecology
Center for Reproductive Medicine
P.O. Box 22660
Amsterdam
1100 DD
Netherlands
Phone | +31 (0)20 566 4355 or +31 (0)20 566 9111 |
---|---|
i.m.custers@amc.uva.nl |
Study information
Study design | Randomised, controlled, parallel group multicentre trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Treatment |
Scientific title | Treatment of couples with unexplained subfertility and an unfavourable prognosis: a randomised trial comparing the effectiveness of intrauterine insemination with ovarian hyperstimulation and in-vitro fertilisation with single embryo transfer |
Study acronym | SETI-study (Single Embryo Transfer or IUI) |
Study objectives | One cycle of In-Vitro Fertilisation-elective Single Embryo Transfer (IVF-eSET) followed by transfer of frozen embryos is at least as effective as three cycles of Intra-Uterine Insemination-Controlled Ovarian Hyperstimulation (IUI-COH) in terms of ongoing pregnancy. Multiple pregnancies however can largely be prevented by treating women with IVF-eSET. |
Ethics approval(s) | Approval received from the ethics board of the Academic Medical Centre Amsterdam on March 6th 2006 (reference number: MEC 294). |
Health condition(s) or problem(s) studied | Unexplained Subfertility |
Intervention | Comparison of IVF in a long protocol with elective Single Embryo Transfer, and IUI-COH, in couples with unexplained or mild male subfertility and poor fertility prospects. |
Intervention type | Other |
Primary outcome measure | Ongoing pregnancy defined as registered heartbeat on ultrasound beyond 12 weeks of gestation. |
Secondary outcome measures | 1. Multiple pregnancy, defined as registered heartbeat of at least two foetuses at 12 weeks of gestation 2. Clinical pregnancy, defined as any registered embryonic heartbeat at sonography 3. Live birth, defined as the birth of at least one living child 4. Pregnancy complications (preterm birth less than 37 weeks, birth weight less than 2.5 gram, Pregnancy Induced Hypertension (PIH), (pre-) eclampsia, Haemolysis, Elevated Liver, Low Platelet [HELLP]) |
Overall study start date | 01/06/2006 |
Completion date | 01/06/2008 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Female |
Target number of participants | 100 |
Total final enrolment | 116 |
Key inclusion criteria | 1. Female age between 18 and 36 years 2. Couples must be diagnosed with unexplained subfertility, defined as normal semen (pre-wash total motile sperm count of at least 40 million), spontaneous ovulatory cycle and patent Fallopian tubes, or with mild male subfertility, defined as a post-wash total motile sperm count above three million 3. The couple has poor fertility prospects as calculated by the validated model of Hunault. A poor fertility prospect is defined as a chance of spontaneous pregnancy below 30% within 12 months |
Key exclusion criteria | 1. Polycystic ovary syndrome 2. Endocrinopathological disease like: Cushing syndrome, adrenal hyperplasia, hyperprolactinemia, acromegaly, imminent ovarian failure, premature ovarian failure, hypothalamic amenorrhea, hypothyroidy, diabetes mellitus type I 3. If not willing or able to sign the consent form |
Date of first enrolment | 01/06/2006 |
Date of final enrolment | 01/06/2008 |
Locations
Countries of recruitment
- Netherlands
Study participating centre
Academic Medical Center (AMC)
Amsterdam
1100 DD
Netherlands
1100 DD
Netherlands
Sponsor information
Academic Medical Center (AMC) (The Netherlands)
Hospital/treatment centre
Hospital/treatment centre
P.O. Box 22660
Amsterdam
1100 DD
Netherlands
Website | http://www.amc.uva.nl/#http://www.amc.uva.nl/ |
---|---|
https://ror.org/03t4gr691 |
Funders
Funder type
Industry
Organon (The Netherlands)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 01/11/2011 | 14/01/2021 | Yes | No |
Editorial Notes
14/01/2021: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the reference.
3. The NTR numbers have been added.